Search

everythinglearnresearchcommunity

for

Search:↓

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

PRP is not a stem cell treatment and should not be marketed as such.

Androgens can help prevent memory problems caused by apoE4.

Oxidative stress, not insulin resistance, is significantly related to free androgen index in PCOS.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Minocycline may cause hair loss by increasing DHT levels, but finasteride can help counteract this effect.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Understanding how mesenchymal stem cells stay undifferentiated can improve their use in treating diseases.

Lifestyle changes can significantly improve hair loss in overweight women with PCOS.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

Finasteride affects frog testes by increasing testosterone, decreasing 5α-DHT, and impacting genes related to reproduction and other functions.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.